Sara Merler

724 total citations
12 papers, 42 citations indexed

About

Sara Merler is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Sara Merler has authored 12 papers receiving a total of 42 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Sara Merler's work include Prostate Cancer Treatment and Research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Sara Merler is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Sara Merler collaborates with scholars based in Italy, Switzerland and Malaysia. Sara Merler's co-authors include Alessandro Rizzo, Matteo Santoni, Marco Oderda, Giulia Sorgentoni, Francesco Massari, Veronica Mollica, Gennaro Gadaleta‐Caldarola, Sabrina Vari, Rolando Nortilli and Ricardo Pereira Mestre and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Sara Merler

7 papers receiving 42 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Merler Italy 4 28 18 17 14 9 12 42
Joonatan Sipola Finland 2 47 1.7× 15 0.8× 42 2.5× 14 1.0× 7 0.8× 2 59
Verena Friedl United States 4 19 0.7× 9 0.5× 21 1.2× 21 1.5× 9 1.0× 7 43
Dominique Spaëth France 4 64 2.3× 17 0.9× 29 1.7× 12 0.9× 33 3.7× 6 76
Elena Almagro Spain 5 31 1.1× 22 1.2× 19 1.1× 16 1.1× 5 0.6× 9 57
Jane Foo Canada 4 20 0.7× 13 0.7× 18 1.1× 33 2.4× 7 0.8× 5 51
Qilong Zhang China 4 29 1.0× 41 2.3× 14 0.8× 10 0.7× 11 1.2× 9 50
Flavia Cantile Italy 3 23 0.8× 24 1.3× 10 0.6× 15 1.1× 4 0.4× 3 41
Javad Saghebi Australia 2 37 1.3× 20 1.1× 11 0.6× 9 0.6× 29 3.2× 8 50
A. Montesa Spain 5 40 1.4× 17 0.9× 19 1.1× 19 1.4× 7 0.8× 16 54
Jade M. van Berge Henegouwen Netherlands 4 18 0.6× 27 1.5× 10 0.6× 6 0.4× 7 0.8× 12 40

Countries citing papers authored by Sara Merler

Since Specialization
Citations

This map shows the geographic impact of Sara Merler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Merler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Merler more than expected).

Fields of papers citing papers by Sara Merler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Merler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Merler. The network helps show where Sara Merler may publish in the future.

Co-authorship network of co-authors of Sara Merler

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Merler. A scholar is included among the top collaborators of Sara Merler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Merler. Sara Merler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Merler, Sara, Luís Castelo-Branco, Ricardo Pereira Mestre, et al.. (2025). The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages. International Journal of Molecular Sciences. 26(1). 318–318. 1 indexed citations
2.
3.
4.
5.
Merler, Sara, Fabio Turco, Elena Trevisi, et al.. (2024). Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis. European Urology Oncology. 7(6). 1199–1215. 7 indexed citations
6.
Rizzo, Alessandro, Veronica Mollica, Sara Merler, et al.. (2022). Incidence of grade 3–4 adverse events, dose reduction, and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysis. Expert Opinion on Drug Metabolism & Toxicology. 18(3). 235–240. 7 indexed citations
7.
Merler, Sara, et al.. (2022). Remarkable response to gemcitabine rechallenge in advanced urothelial carcinoma: a case report. Anti-Cancer Drugs. 33(10). 1171–1174.
8.
Rizzo, Alessandro, Sara Merler, Giulia Sorgentoni, et al.. (2021). Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysis. Expert Opinion on Drug Metabolism & Toxicology. 17(10). 1237–1243. 15 indexed citations
9.
Iacovelli, Roberto, Sebastiano Buti, Consuelo Buttigliero, et al.. (2020). Avelumab as single agent for patients with metastatic or locally advanced urothelial cancer PD-L1+ unfit for cisplatin: The ARIES study.. Journal of Clinical Oncology. 38(6_suppl). TPS596–TPS596.
10.
Merler, Sara, Daniela Tregnago, Massimiliano Casali, et al.. (2020). 1723P Organizational challenges and oncological activity volumes during the SARS-CoV-2 epidemic peak in Verona, Italy. Annals of Oncology. 31. S1011–S1011.
11.
Carbognin, Luisa, Isabella Sperduti, Mariangela Ciccarese, et al.. (2016). Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival. The Breast. 29. 24–30. 9 indexed citations
12.
Carbognin, Luisa, Isabella Sperduti, Matteo Brunelli, et al.. (2016). Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage ‘pure’ and ‘mixed’ lobular breast cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 50–50. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joonatan Sipola Breakdown of academic impact, for papers by Verena Friedl Breakdown of academic impact, for papers by Dominique Spaëth Breakdown of academic impact, for papers by Elena Almagro Breakdown of academic impact, for papers by Jane Foo Breakdown of academic impact, for papers by Qilong Zhang Breakdown of academic impact, for papers by Flavia Cantile Breakdown of academic impact, for papers by Javad Saghebi Breakdown of academic impact, for papers by A. Montesa Breakdown of academic impact, for papers by Jade M. van Berge Henegouwen
Rankless by CCL
2026